March 2, 2023

Groups and individuals that are required to participate in the 2022 Merit-based Incentive Payment System (MIPS) have until 8 pm ET, March 31, to submit their performance data to the Centers for Medicare and Medicaid Services (CMS). The American College of Radiology® (ACR®) Qualified Clinical Data Registry (QCDR) team advises submitting the data in advance of the March 31 deadline to ensure it is received with no errors.

Most radiology practices will be required to submit quality measures and improvement activities to CMS but are likely to be exempted from the promoting interoperability performance category. The performance threshold for 2022 is 75 points — the highest MIPS threshold thus far. Any groups or individuals that score below 75 points will be subject to a negative payment adjustment for the 2024 payment year.

Practices using the College’s QCDR to submit to MIPS can complete their submission using the CMS Submission tab in the MIPS Participation Portal dashboard.

For questions about MIPS or completing submission using ACR QCDR, contact Zach Smith, ACR Senior Quality Programs Specialist.


Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more